Oncologic impact of delaying radical prostatectomy in men with intermediate- and high-risk prostate cancer: a systematic review

[1]  T. Ahlering,et al.  Management of patients who opt for radical prostatectomy during the coronavirus disease 2019 (COVID‐19) pandemic: an international accelerated consensus statement , 2020, BJU international.

[2]  D. Patt,et al.  Impact of COVID-19 on Cancer Care: How the Pandemic Is Delaying Cancer Diagnosis and Treatment for American Seniors , 2020, JCO clinical cancer informatics.

[3]  T. Skolarus,et al.  The Impact of the COVID-19 Pandemic on Genitourinary Cancer Care: Re-envisioning the Future , 2020, European Urology.

[4]  C. Iselin,et al.  Timing and delay of radical prostatectomy do not lead to adverse oncologic outcomes: results from a large European cohort at the times of COVID-19 pandemic , 2020, World Journal of Urology.

[5]  S. Pridgeon,et al.  Delay to radical prostatectomy: Who, why and does it matter? , 2020 .

[6]  A. Kural,et al.  Management of prostate cancer patients during COVID-19 pandemic , 2020, Prostate Cancer and Prostatic Diseases.

[7]  R. Campi,et al.  A Global Survey on the Impact of COVID-19 on Urological Services , 2020, European Urology.

[8]  V. Margulis,et al.  Active Surveillance for Intermediate-Risk Prostate Cancer: Systematic Review and Meta-analysis of Current Protocols and Outcomes. , 2020, Clinical genitourinary cancer.

[9]  T. Powles,et al.  Risks from Deferring Treatment for Genitourinary Cancers: A Collaborative Review to Aid Triage and Management During the COVID-19 Pandemic☆ , 2020, European Urology.

[10]  A. George,et al.  Delayed Radical Prostatectomy is Not Associated with Adverse Oncological Outcomes: Implications for Men Experiencing Surgical Delay Due to the COVID-19 Pandemic. , 2020, The Journal of urology.

[11]  M. Babjuk,et al.  European Association of Urology Guidelines Office Rapid Reaction Group: An Organisation-wide Collaborative Effort to Adapt the European Association of Urology Guidelines Recommendations to the Coronavirus Disease 2019 Era☆ , 2020, European Urology.

[12]  K. Zorn,et al.  Impact of surgical wait times during summer months on the oncological outcomes following robotic-assisted radical prostatectomy: 10 years’ experience from a large Canadian academic center , 2020, World Journal of Urology.

[13]  K. Yuen,et al.  Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.

[14]  Ashutosh,et al.  Management of patients who opt for radical prostatectomy during the COVID-19 pandemic: An International Accelerated Consensus Statement. , 2020 .

[15]  M. Cooperberg,et al.  Evaluating the Safety of Active Surveillance: Outcomes of Deferred Radical Prostatectomy after an Initial Period of Surveillance. , 2019, The Journal of urology.

[16]  R. Thompson,et al.  Impact of time from biopsy to surgery on complications, functional and oncologic outcomes following radical prostatectomy , 2019, International braz j urol : official journal of the Brazilian Society of Urology.

[17]  K. Trpkov,et al.  The effect of time from biopsy to radical prostatectomy on adverse pathologic outcomes , 2019, Research and reports in urology.

[18]  A. Partin,et al.  Evaluating the impact of length of time from diagnosis to surgery in patients with unfavourable intermediate‐risk to very‐high‐risk clinically localised prostate cancer , 2019, BJU international.

[19]  M. Savaş,et al.  Impact of Delay from Biopsy to Surgery on the Rate of Adverse Pathologic and Oncologic Outcomes for Clinically Localized Prostate Cancer , 2018, The Bulletin of Urooncology.

[20]  S. Fosså,et al.  Is time from diagnosis to radical prostatectomy associated with oncological outcomes? , 2018, World Journal of Urology.

[21]  J. Hugosson,et al.  Long‐Term Outcomes after Deferred Radical Prostatectomy in Men Initially Treated with Active Surveillance , 2018, The Journal of urology.

[22]  E. Faria,et al.  Time between diagnosis and surgical treatment on pathological and clinical outcomes in prostate cancer: does it matter? , 2018, World Journal of Urology.

[23]  F. Montorsi,et al.  Evaluating the effect of time from prostate cancer diagnosis to radical prostatectomy on cancer control: Can surgery be postponed safely? , 2017, Urologic oncology.

[24]  F. Saad,et al.  Does surgical delay for radical prostatectomy affect biochemical recurrence? A retrospective analysis from a Canadian cohort , 2017, World Journal of Urology.

[25]  P. Carroll,et al.  Immediate versus delayed radical prostatectomy: updated outcomes following active surveillance of prostate cancer. , 2015, European urology.

[26]  K. Badani,et al.  Delay from biopsy to radical prostatectomy influences the rate of adverse pathologic outcomes , 2015, The Prostate.

[27]  M. Terris,et al.  Delayed radical prostatectomy for intermediate‐risk prostate cancer is associated with biochemical recurrence: Possible implications for active surveillance from the SEARCH database , 2013, The Prostate.

[28]  J. McKiernan,et al.  Effect of delaying surgery on radical prostatectomy outcomes: a contemporary analysis , 2012, BJU international.

[29]  Kirsten L. Greene,et al.  Outcomes of active surveillance for men with intermediate-risk prostate cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  J. Ioannidis,et al.  The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration , 2009, Annals of Internal Medicine [serial online].